ADD+G Attorney Clay D. Shorrock Counsels LineaRx, Inc. in Successful Asset Acquisition of Vitatex, Inc.

ADD+G attorney Clay D. Shorrock recently represented LineaRx, Inc., a New York based biotechnology company focused on the use of polymerase chain reaction (PCR) derived DNA in gene therapy, immuno-oncology and diagnostics, in the asset acquisition of Vitatex, Inc., a biotechnology company focused on the capture and detection of invasive circulating tumor cells (iCTCs). The acquired assets will be further developed by LineaRx to bolster its immuno-oncology and diagnostics pipelines.